Alimera Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
Update On Currently Recommended Stocks
Article By: SmithOnStocks
Monday, September 25, 2017 4:19 PM EDT
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read
Alimera Sciences: Company Achieves Breakeven Pretax Cash Flow In 2Q, 2017 Despite Slow Unit Demand For Iluvien
Article By: SmithOnStocks
Monday, August 14, 2017 1:42 PM EDT
Alimera has made dramatic improvements in its cash flow situation and has done a very respectable job in building sales. Alimera is not far away from being a cash generating, profitable pharmaceutical company.
In this article: ALIM
Read
Morning Call For Sept. 29, 2014
Article By: Jim Van Meerten
Monday, September 29, 2014 9:48 AM EDT
December E-mini S&Ps (ESZ14 -0.62%) this morning are down -0.63% and European stocks are down -0.57% after Eurozone Sep economic confidence fell to a 10-month low.
In this article: F, FDX, FGP, NI, OFC, RTN, ALIM, SGEN, SLXP, CTAS
Read
Using Mean Reversion And Momentum For Possible Advantage
Article By: David Merkel
Monday, September 1, 2014 8:52 AM EDT
One of the challenges of fundamental investing is trying to find decent ideas that are off the radar.
In this article: AAV, AKS, DYN, LPL, STV, FJTSF, ALIM, CTRN, MSLPE, BBRY (NOW BB)
Read
E Weekly Stock Report
Article By: E.B. Capital Markets
Tuesday, June 3, 2014 11:03 AM EDT
The top scoring sector remains utilities. Consumer goods, industrial goods, and healthcare also score above average. Financials, services, basics, and technology score below average.
In this article: AN, APH, AVB, AZO, CSX, EQT, GB, GD, LO, NEE, ALIM, ECOL, AGYS, CTRN, ORLY, SIAL, EFA, SPY, XLU, ABBV
Read

PARTNER HEADLINES

Latest Tweets for $ALIM

No tweets yet!